AZ St-Lucas Trials - LARVOL Sigma

AZ St-Lucas	Welcome, Profile Billing Logout

Trial + Data / Events

Status

Region

Interventions

Sponsor

Conditions

Primary compl

Study compl

Arts, Joris

NCT05815602: Ebastine Versus Mebeverine in IBS Patients

Recruiting

200

Europe

Ebastine, Duspatalin

Guy Boeckxstaens, Fund for Scientific Research, Flanders, Belgium

IBS - Irritable Bowel Syndrome, IBS

10/27

01/28

NCT05353985 / 2020-005438-14: A Study of TAK-062 in Treatment of Active Celiac Disease in Participants Attempting a Gluten-Free Diet

Completed

153

Europe, Canada, US

TAK-062, Simulated Inadvertent Gluten Exposure (SIGE) Gluten-Bar, TAK-062 Placebo, Simulated Inadvertent Gluten Exposure (SIGE) Gluten-free Bar

Takeda

Celiac Disease

11/24

DORI, NCT05808023: Dose-dependent FODMAP Reintroduction in IBS

Recruiting

N/A

Europe

FODMAP powder reintroduction

Universitaire Ziekenhuizen KU Leuven, AZ Sint-Lucas Brugge

Irritable Bowel Syndrome

10/24

12/24

NCT05780749: A 14-week Pilot Prospective Clinical Trial With BiOkuris Product in Patients With Irritable Bowel Syndrome

Recruiting

N/A

130

Europe

DDI-IBS-001, DDDI-IBS-001 placebo

Biokuris s.a.

Irritable Bowel Syndrome

12/24

Maerten, Tania

NCT03464305 / 2017-001397-41: ASPIRIN Trial Belgium

Active, not recruiting

148

Europe

acetylsalicylic acid, Placebo

University Hospital, Antwerp, Kom Op Tegen Kanker, Anticancerfund

Colon Cancer

12/27

NALPAC, NCT05472259 / 2020-003889-39: A Study Evaluating the Efficacy of 5-FU + NALIRI and 5-FU + NALIRINOX for PDAC

Recruiting

134

Europe

Nanoliposomal irinotecan, Onyvide, 5 FU, Fluorouracil, Leucovorin, Folinate, Elvorine, Oxaliplatin

Belgian Group of Digestive Oncology, University Hospital St Luc, Brussels

Metastatic Pancreatic Ductal Adenocarcinoma

12/26

12/27

Voorde, Lien Van De

THUNDER, NCT06282588: Treatment of High-Risk Prostate Cancer Guided by Novel Diagnostic Radio- and Molecular Tracers

Recruiting

2/3

493

Europe

Darolutamide, Nubeqa, BAY1841788, Darolutamide matched placebo, BAY1841788 matched placebo, Radiotherapy, Zoladex 3.6Mg Implant, Goserelin acetate 3.6 mg, Zoladex LA, Goserelin acetate 10.8 mg, Decapeptyl sustained release 22.5 mg, Triptorelin 11.25 mg, Decapeptyl sustained release 11.25 mg, Depo-Eligard 45 mg, Leuprorelin acetate 45 mg, Depo-Eligard 22.5 mg, Leuprorelin acetate 22.5 mg, Depo-Eligard 7.5 mg, Leuprorelin acetate 7.5 mg, Firmagon 120 MG Injection, Degarelix 40 mg, Firmagon 80 MG Injection, Degarelix 20 mg, Docetaxel, Taxotere

Cancer Research Antwerp, Bayer, Veracyte, Inc.

Prostate Cancer

07/30

12/30

DART, NCT04641078: Stereotactic Body Radiotherapy With or Without Darolutamide for OligoRecurrent Prostate Cancer

Recruiting

124

Europe

Darolutamide, metastasis-directed treatment

University Hospital, Ghent

Prostate Cancer, Prostate Cancer Recurrent, Prostate Cancer Metastatic, Metastatic Cancer, Oligometastasis

02/26

Holvoet, Liesbeth

NALPAC, NCT05472259 / 2020-003889-39: A Study Evaluating the Efficacy of 5-FU + NALIRI and 5-FU + NALIRINOX for PDAC

Recruiting

134

Europe

Nanoliposomal irinotecan, Onyvide, 5 FU, Fluorouracil, Leucovorin, Folinate, Elvorine, Oxaliplatin

Belgian Group of Digestive Oncology, University Hospital St Luc, Brussels

Metastatic Pancreatic Ductal Adenocarcinoma

12/26

12/27

Bellens, Koen

NCT05815602: Ebastine Versus Mebeverine in IBS Patients

Recruiting

200

Europe

Ebastine, Duspatalin

Guy Boeckxstaens, Fund for Scientific Research, Flanders, Belgium

IBS - Irritable Bowel Syndrome, IBS

10/27

01/28

NCT01912313: Measuring Nerve Activity in Small Human Intestinal Biopsies in IBS (Irritable Bowel Syndrome)

Recruiting

N/A

99999999

Europe

Rectal biopsies from IBS patients or healthy subjects will be taken during proctoscopy

KU Leuven

IBS, Healthy

08/25

NCT02010983: Achalasia and Dysplasia

Recruiting

N/A

Europe

chromoendoscopy

KU Leuven

Dysplasia in Longstanding Achalasia, Relation Between Food Stasis and Dysplasia

12/25

Glorieux, Mary

NCT05815602: Ebastine Versus Mebeverine in IBS Patients

Recruiting

200

Europe

Ebastine, Duspatalin

Guy Boeckxstaens, Fund for Scientific Research, Flanders, Belgium

IBS - Irritable Bowel Syndrome, IBS

10/27

01/28

Trial + Data / Events

Status

Region

Interventions

Sponsor

Conditions

Primary compl

Study compl

Arts, Joris

NCT05815602: Ebastine Versus Mebeverine in IBS Patients

Recruiting

200

Europe

Ebastine, Duspatalin

Guy Boeckxstaens, Fund for Scientific Research, Flanders, Belgium

IBS - Irritable Bowel Syndrome, IBS

10/27

01/28

NCT05353985 / 2020-005438-14: A Study of TAK-062 in Treatment of Active Celiac Disease in Participants Attempting a Gluten-Free Diet

Completed

153

Europe, Canada, US

TAK-062, Simulated Inadvertent Gluten Exposure (SIGE) Gluten-Bar, TAK-062 Placebo, Simulated Inadvertent Gluten Exposure (SIGE) Gluten-free Bar

Takeda

Celiac Disease

11/24

DORI, NCT05808023: Dose-dependent FODMAP Reintroduction in IBS

Recruiting

N/A

Europe

FODMAP powder reintroduction

Universitaire Ziekenhuizen KU Leuven, AZ Sint-Lucas Brugge

Irritable Bowel Syndrome

10/24

12/24

NCT05780749: A 14-week Pilot Prospective Clinical Trial With BiOkuris Product in Patients With Irritable Bowel Syndrome

Recruiting

N/A

130

Europe

DDI-IBS-001, DDDI-IBS-001 placebo

Biokuris s.a.

Irritable Bowel Syndrome

12/24

Maerten, Tania

NCT03464305 / 2017-001397-41: ASPIRIN Trial Belgium

Active, not recruiting

148

Europe

acetylsalicylic acid, Placebo

University Hospital, Antwerp, Kom Op Tegen Kanker, Anticancerfund

Colon Cancer

12/27

NALPAC, NCT05472259 / 2020-003889-39: A Study Evaluating the Efficacy of 5-FU + NALIRI and 5-FU + NALIRINOX for PDAC

Recruiting

134

Europe

Nanoliposomal irinotecan, Onyvide, 5 FU, Fluorouracil, Leucovorin, Folinate, Elvorine, Oxaliplatin

Belgian Group of Digestive Oncology, University Hospital St Luc, Brussels

Metastatic Pancreatic Ductal Adenocarcinoma

12/26

12/27

Voorde, Lien Van De

THUNDER, NCT06282588: Treatment of High-Risk Prostate Cancer Guided by Novel Diagnostic Radio- and Molecular Tracers

Recruiting

2/3

493

Europe

Cancer Research Antwerp, Bayer, Veracyte, Inc.

Prostate Cancer

07/30

12/30

DART, NCT04641078: Stereotactic Body Radiotherapy With or Without Darolutamide for OligoRecurrent Prostate Cancer

Recruiting

124

Europe

Darolutamide, metastasis-directed treatment

University Hospital, Ghent

Prostate Cancer, Prostate Cancer Recurrent, Prostate Cancer Metastatic, Metastatic Cancer, Oligometastasis

02/26

Holvoet, Liesbeth

NALPAC, NCT05472259 / 2020-003889-39: A Study Evaluating the Efficacy of 5-FU + NALIRI and 5-FU + NALIRINOX for PDAC

Recruiting

134

Europe

Nanoliposomal irinotecan, Onyvide, 5 FU, Fluorouracil, Leucovorin, Folinate, Elvorine, Oxaliplatin

Belgian Group of Digestive Oncology, University Hospital St Luc, Brussels

Metastatic Pancreatic Ductal Adenocarcinoma

12/26

12/27

Bellens, Koen

NCT05815602: Ebastine Versus Mebeverine in IBS Patients

Recruiting

200

Europe

Ebastine, Duspatalin

Guy Boeckxstaens, Fund for Scientific Research, Flanders, Belgium

IBS - Irritable Bowel Syndrome, IBS

10/27

01/28

NCT01912313: Measuring Nerve Activity in Small Human Intestinal Biopsies in IBS (Irritable Bowel Syndrome)

Recruiting

N/A

99999999

Europe

Rectal biopsies from IBS patients or healthy subjects will be taken during proctoscopy

KU Leuven

IBS, Healthy

08/25

NCT02010983: Achalasia and Dysplasia

Recruiting

N/A

Europe

chromoendoscopy

KU Leuven

Dysplasia in Longstanding Achalasia, Relation Between Food Stasis and Dysplasia

12/25

Glorieux, Mary

NCT05815602: Ebastine Versus Mebeverine in IBS Patients

Recruiting

200

Europe

Ebastine, Duspatalin

Guy Boeckxstaens, Fund for Scientific Research, Flanders, Belgium

IBS - Irritable Bowel Syndrome, IBS

10/27

01/28



	Diseases Companies Products Productz Mechanisms of Action Sites